Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy

QR Code

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy

Purpose: To define the incidence and impact of tearing in patients receiving adjuvant docetaxel-based chemotherapy and assess for lacrimal duct obstruction (LDO) as a causative factor. Patients and Methods: Consecutive patients with early breast cancer recommended for docetaxel-based chemotherapy wi...

Full description

Bibliographic Details
Main Authors:	Chan, Arlene, Su, Charles, De Boer, Richard, Gajdatsy, Adam
Format:	Journal Article
Published:	American Society of Clinical Oncology 2013
Online Access:	http://hdl.handle.net/20.500.11937/39187

Similar Items

Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients
by: Chan, Arlene, et al.
Published: (2014)

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)

Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens
by: Chan, Arlene, et al.
Published: (2018)

Vomiting in docetaxel chemotherapy: which to blame, dose or gene?
by: Jabir, Rafid, et al.
Published: (2014)

Factors associated with delayed time to adjuvant chemotherapy in stage III colon cancer
by: Chan, Arlene, et al.
Published: (2014)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
by: Mackey, J., et al.
Published: (2016)

Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy
by: Mirakhorli, Mojgan, et al.
Published: (2013)

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study
by: Au, H., et al.
Published: (2013)

Wives tearfully receive husbands degrees, father receives sons diploma
by: Sakinah, Abdullah, et al.
Published: (2022)

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
by: Bergh, J., et al.
Published: (2012)

Use of non anthracycline regimens in early stage breast cancer within Australia
by: De Boer, R., et al.
Published: (2011)

Husband and wife tearfully receive Posthumous Award for son
by: Nor Salwana, Mohammad Idris
Published: (2022)

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
by: Eiermann, W., et al.
Published: (2011)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Prevalence and predictors of depression among oncology patients receiving chemotherapy in government hospitals in Peninsular Malaysia
by: Remesh Kumar, Mamta Vesudave, et al.
Published: (2019)

Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study)
by: Chan, Arlene, et al.
Published: (2017)

Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix
by: Rahman, Cheryl V., et al.
Published: (2013)

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2010)

Prevalence and predictors of depression and anxiety among oncology patients receiving chemotherapy in public hospitals in Peninsular Malaysia
by: Remesh Kumar, Mamta Vesudave
Published: (2018)

The prevalence of skin tears in the acute care setting in Singapore
by: Chang, Y., et al.
Published: (2016)

Cancer chemotherapy in early life significantly alters the maturation of pain processing
by: Hathway, Gareth J., et al.
Published: (2017)

Overexpression of activated phospholipase C?1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy
by: Lattanzio, R., et al.
Published: (2013)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)

Social support, depression, anxiety and stress among breast cancer patients receiving chemotherapy in Hospital Universiti Sains Malaysia
by: Rokhman, Nik Nor Izwana
Published: (2024)

Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)

Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
by: Chan, Arlene, et al.
Published: (2012)

Stress and coping strategies of patients receiving chemotherapy at Hospital Universiti Sains Malaysia
by: Ismail, Hasnida
Published: (2016)

Development without the tears
by: Abd Razak, Dzulkifli
Published: (2006)

The impact on sexual functioning of chemotherapy-induced menopause in women with breast cancer.
by: Rogers, M., et al.
Published: (2002)

Predictive Factors For Neutropenia During Chemotherapy Treatment In Breast Cancer Patients
by: Ong, Chiew Wai
Published: (2017)

Formulation of a sustained release docetaxel loaded cockle shell-derived calcium carbonate nanoparticles against breast cancer
by: Ibrahim Hammadi, Nahidah, et al.
Published: (2017)

Posterior cruciate ligament tear
by: Abidin, Mohd Radhwan
Published: (2019)

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)

Depression, anxiety and streee in young adult breast cancer women undergoing adjuvant therapy in HUSM
by: Leng, Leong Yee
Published: (2011)

Fatigue and sleep quality among cancer patients receiving chemotherapy in Hospital Universiti Sains Malaysia
by: Phey, Cheong Phey
Published: (2024)

Baseline values of canine tear production determined by schirmer tear and phenol red thread tests.
by: Aw, Melissa Hey Mun, et al.
Published: (2010)

Nutritional status and health-related quality of life of breast cancer patients on chemotherapy
by: Lua, Pei Lin, et al.
Published: (2012)

Development and validation of spiritual care module for breast cancer women undergoing chemotherapy
by: Shili, Cheng
Published: (2025)

Genetic determinants of TAC chemotherapy response in triple negative breast cancer patients
by: Aziz, Ahmad Aizat Abdul
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_at02nsinvkkro80i6dqa5b6me8